Predictive Models for Hypoglycemia Risk in Haemodialysis Patients With Diabetic Kidney Disease: Systematic Review and Meta-Analysis.
Yuxin Xiong, Mengzhen Huang, Hongyan Li et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis evaluated hypoglycemia risk prediction models in haemodialysis patients with diabetic kidney disease. Six studies were included, with a pooled area under the curve (AUC) of 0.846 (95% CI: 0.823-0.867), indicating satisfactory discriminatory ability. However, most studies had a high risk of bias, highlighting the need for further validation.
Key findings
- The pooled AUC value of the six studies was 0.846 (95% CI: 0.823-0.867).
- Four studies were rated as having a high risk of bias.
- All six models demonstrated good overall applicability.
- Two studies performed internal validation, while three conducted external validation.
Why it matters
Understanding hypoglycemia risk in diabetic kidney disease patients undergoing haemodialysis is crucial for improving patient safety and outcomes. Reliable prediction models can aid in early identification and management of hypoglycemia risk.
What to keep in mind
Most original studies had a high risk of bias and lacked adequate validation.